Table 5.
Multivariate analyses of the possible risk factors for the 28-day mortality and failure of nonsurgical treatment.
| 28-day mortality | Failure of nonsurgical treatment | |||||
|---|---|---|---|---|---|---|
| OR | 95% CI | p value | OR | 95% CI | p value | |
| Age (per year) | 1.04 | 1.02–1.13 | 0.031 | 0.93 | 0.65–1.56 | 0.095 |
| Sex (male) | 1.26 | 0.79–1.54 | 0.298 | 1.02 | 0.84–1.23 | 0.302 |
| BMI (kg/m2) | ||||||
| 18.5–25 | 1 (reference) | 1 (reference) | ||||
| <18.5 | 1.16 | 0.82–1.91 | 0.247 | 1.08 | 0.73–1.48 | 0.495 |
| >25 | 0.87 | 0.53–1.03 | 0.064 | 0.96 | 0.57–1.28 | 0.251 |
| APACHE II (per point) | 1.04 | 1.01–1.11 | 0.006 | 1.05 | 1.01–1.23 | 0.029 |
| SOFA (per point) | 1.06 | 1.02–1.17 | <0.001 | 1.08 | 1.03–1.14 | <0.001 |
| Mechanically ventilated | 1.53 | 1.24–2.06 | 0.026 | 1.25 | 0.93–1.92 | 0.060 |
| Receiving vasoactive drugs | 2.14 | 1.55–2.76 | 0.018 | 1.09 | 0.89–1.58 | 0.081 |
| Receiving IV opioid | 0.96 | 0.46–1.25 | 0.213 | 0.83 | 0.33–3.48 | 0.607 |
| Acute gut wall thickening (edema) | 1.14 | 1.03–1.29 | 0.047 | 1.51 | 1.27–1.69 | <0.001 |
| Receiving pharmacologic paralysis | 1.02 | 0.83–2.31 | 0.365 | 0.99 | 0.72–2.27 | 0.212 |
OR: odds ratio; CI: confidence interval; BMI: body mass index; APACHE II: Acute Physiology and Chronic Health Evaluation II; SOFA: Sequential Organ Failure Assessment.